J&J Keeps Cheap Risperdal Off Shelves
By Christine Caulfield · May 11, 2007, 12:00 AM EDT
In a win for Johnson & Johnson, a U.S. appeals court has upheld a ban on the sale of a cheap version of the pharmaceutical giant's antipsychotic drug Risperdal for the...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login